Literature DB >> 10592936

Chemokines and renal inflammation.

U Panzer1, R A Stahl.   

Abstract

The appearance of inflammatory cells at the site of tissue injury is a hallmark of almost any renal disease. Infiltrating leukocytes mediate the initiation and progression of damage by direct cytotoxicity, the secretion of soluble factors, or by the regulation of the immune response. Particularly mononuclear phagocytes are present in almost any kidney disease and contribute to the development of injury (1, 2). Before leukocytes can exert their effects on renal damage or repair, they have to reach the site of injury. In the recent years, it has become clear that a group of small proteins called chemokines play a crucial role in the regulation of leukocyte trafficking and activation. In this review, we summarize the existent evidence that chemokines may act in the initiation of renal inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592936

Source DB:  PubMed          Journal:  Nephrologie        ISSN: 0250-4960


  4 in total

1.  Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells.

Authors:  Latika Dhawan; Bin Liu; Allison Pytlak; Satyarth Kulshrestha; Burns C Blaxall; Mark B Taubman
Journal:  Mol Cell Biol       Date:  2012-07-16       Impact factor: 4.272

2.  Protein kinase Cδ mediates MCP-1 mRNA stabilization in vascular smooth muscle cells.

Authors:  Bin Liu; Latika Dhawan; Burns C Blaxall; Mark B Taubman
Journal:  Mol Cell Biochem       Date:  2010-07-04       Impact factor: 3.396

3.  Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes.

Authors:  Miran A Jaffa; Firas Kobeissy; Moustafa Al Hariri; Hussein Chalhoub; Assaad Eid; Fuad N Ziyadeh; Ayad A Jaffa
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 4.  Chemokine receptors in epithelial ovarian cancer.

Authors:  Goda G Muralidhar; Maria V Barbolina
Journal:  Int J Mol Sci       Date:  2013-12-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.